YK BIOVENTURES OPPORTUNITIES GP I, LLC sold 16.2% of their position (3.66M shares) of CERO THERAPEUTICS HOLDINGS, INC. on the open market
Open‑market sale worth $383.4K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 12/10/2024ACC: 0001415889-24-028899
→
10% Owner
Since Sep 2024
-3.66M
Net shares
Net seller
$383.4K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
3.66M disposed
Non-Derivative Transactions3
Common Stock
Indirect
Shares
−1.24M
Price / share
$0.12
Trade value
$148.42K
% of position
5.5%
12/6/2024
22.62M→21.38M
Common Stock
Indirect
Shares
−850.54K
Price / share
$0.11
Trade value
$93.56K
% of position
4.0%
12/9/2024
21.38M→20.53M
Common Stock
Indirect
Shares
−1.57M
Price / share
$0.09
Trade value
$141.39K
% of position
7.7%
12/10/2024
20.53M→18.96M
Total
Net shares
−3.66M
Net value
-$383.37K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 12/6/2024 | S · Sale | −1.24M | $0.12 | $148.42K | 5.5% | 22.62M | 21.38M |
| Common Stock Indirect | 12/9/2024 | S · Sale | −850.54K | $0.11 | $93.56K | 4.0% | 21.38M | 20.53M |
| Common Stock Indirect | 12/10/2024 | S · Sale | −1.57M | $0.09 | $141.39K | 7.7% | 20.53M | 18.96M |
| Total | −3.66M | -$383.37K | ||||||
Derivative Transactions0
No derivative transactions reported